Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-18

Clinical Trial Update: Treating Heart Failure With Enhanced External Counterpulsation (EECP)

View source ↗

Summary

This clinical trial evaluating enhanced external counterpulsation (EECP) for heart failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Heart Failure | Status: WITHDRAWN